A global pandemic of unprecedented proportions demands an unprecedented coordinated global response. Since the COVID-19 crisis began, we have seen unprecedented levels of collaboration among pharmaceutical companies, research centres, universities and governments. Learn more about the local and global response and the race to discover, develop and deliver new medicines and vaccines for COVID-19.

 

Industry Response to COVID-19: Vaccines and Treatments

When: June 24, 2020, 11-11:45 AM MDT

Agenda

11:00 a.m. Introductions: Robb Stoddard, President & CEO, BioAlberta

11:10 a.m. Presentation: Pamela Fralick, President, Innovative Medicines Canada

11:25 a.m. Questions & Answers

11:40 a.m. Closing remarks

* Priority will be given to questions sent in prior to event (submit to Trish@Bioalberta.com). Questions may also be sent online in chat during event.

 

Register here now.

 

About the Presentor:

 

Pamela Fralick, President

Innovative Medicines Canada

 

Pamela Fralick is an experienced leader who has been fostering positive change in Canada’s health sector for decades. Throughout her career, Ms. Fralick has distinguished herself in a variety of senior roles. A convener and innovator, Ms. Fralick is one of Canada’s leading, compassionate voices in the health sector. As the President of Innovative Medicines Canada, Ms. Fralick leads the industry association for Canada’s innovative pharmaceutical companies, working with its members and communities to ensure Canadians have access to the medicines they need, when they need them.